European Medicines Agency Lists Guillen Barre’ Syndrome As Possible Side Effect of AstraZeneka Vaccine 

Want Instant Blog Updates?

Get an email whenever we publish a new article!
PLEASE NOTE:
This subscribe option does not work in some browsers with ad blockers. To ensure your sign up request goes through, use the Google Chrome browser when confirming your subscription from your inbox.

May 31, 2022 

AstraZeneca’s COVID-19 shot joins the list of vaccines flagged for Guillain-Barre syndrome just two months after the FDA identified the same in Johnson & Johnson’s COVID-19 vaccine.

Access the complete Fierce Pharma article here

Access the April 2021 Case Report titled ‘Guillain-Barre syndrome following the first dose of the chimpanzee adenovirus-vectored COVID-19 vaccine, ChAdOx1’ here

 

https://www.givesendgo.com/FreedomofChoicefromVaccineMandate

We've got a lot to talk about

Read More